Adjunctive Therapy of Andrographolid Sulfonatein Community Acquired Pneumonia
Status:
Unknown status
Trial end date:
2019-06-30
Target enrollment:
Participant gender:
Summary
Adjunctive Therapy of AndrographolidSulfonate in Community Acquired Pneumonia: A Multicenter,
Randomized,Double-blinded, Placebo Controlled Clinical Trial. The hypothesis is that
combination therapy with Andrographolid Sulfonatein injection and antibacterial is
significantly better than antibacterial alone in achieving clinical stability among
hospitalized CAP patients.